Cargando…
Lineage plasticity enables low-ER luminal tumors to evolve and gain basal-like traits
Stratifying breast cancer into specific molecular or histologic subtypes aids in therapeutic decision-making and predicting outcomes; however, these subtypes may not be as distinct as previously thought. Patients with luminal-like, estrogen receptor (ER)-expressing tumors have better prognosis than...
Autores principales: | Mohamed, Gadisti Aisha, Mahmood, Sundis, Ognjenovic, Nevena B., Lee, Min Kyung, Wilkins, Owen M., Christensen, Brock C., Muller, Kristen E., Pattabiraman, Diwakar R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9979432/ https://www.ncbi.nlm.nih.gov/pubmed/36859337 http://dx.doi.org/10.1186/s13058-023-01621-8 |
Ejemplares similares
-
Phenotypic heterogeneity driven by plasticity of the intermediate EMT state governs disease progression and metastasis in breast cancer
por: Brown, Meredith S., et al.
Publicado: (2022) -
Pharmacological Induction of mesenchymal-epithelial transition chemosensitizes breast cancer cells and prevents metastatic progression
por: Bagheri, Meisam, et al.
Publicado: (2023) -
Distinct cytosine modification profiles define epithelial-to-mesenchymal cell-state transitions
por: Lee, Min Kyung, et al.
Publicado: (2022) -
The therapeutic response of ER+/HER2− breast cancers differs according to the molecular Basal or Luminal subtype
por: Bertucci, François, et al.
Publicado: (2020) -
Alteration of DNMT1/DNMT3A by eribulin elicits global DNA methylation changes with potential therapeutic implications for triple-negative breast cancer
por: Bagheri, Meisam, et al.
Publicado: (2023)